.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Queensland Health
McKinsey
Cantor Fitzgerald
McKesson
Healthtrust
QuintilesIMS
Deloitte
US Army
Medtronic

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075440

« Back to Dashboard
NDA 075440 describes HALOPERIDOL DECANOATE, which is a drug marketed by West-ward Pharms Int, Mylan Labs Ltd, Gland Pharma Ltd, Sandoz Inc, Hospira, Fresenius Kabi Usa, and Teva Pharms Usa, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the HALOPERIDOL DECANOATE profile page.

The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.

Summary for 075440

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 075440

Suppliers and Packaging for NDA: 075440

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HALOPERIDOL DECANOATE
haloperidol decanoate
INJECTABLE;INJECTION 075440 ANDA Amneal-Agila, LLC 53150-415 53150-415-10 10 VIAL, SINGLE-DOSE in 1 CARTON (53150-415-10) > 1 mL in 1 VIAL, SINGLE-DOSE (53150-415-01)
HALOPERIDOL DECANOATE
haloperidol decanoate
INJECTABLE;INJECTION 075440 ANDA Amneal-Agila, LLC 53150-422 53150-422-05 5 VIAL, MULTI-DOSE in 1 CARTON (53150-422-05) > 5 mL in 1 VIAL, MULTI-DOSE (53150-422-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/ML
Approval Date:Feb 28, 2000TE:AORLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/ML
Approval Date:Feb 28, 2000TE:AORLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Farmers Insurance
Daiichi Sankyo
Boehringer Ingelheim
US Army
UBS
Moodys
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot